메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한면역학회 Immune Network Immune Network Vol.6 No.1
발행연도
2006.3
수록면
43 - 51 (9page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
The DR-70<sup>TM</sup> immunoassay is a newly developed cancer diagnostic test which quantifies the serum fibrin degradation products (FDP), produced during fibrinolysis, by antibody reaction. The purpose of this study was to evaluate the potential of DR-70<sup>TM</sup> Immunoassay in screening malignant tumor. Methods: Sample subjects were 4,169 adults, both male and female, who visited the health promotion center of a general hospital from March 2004 to April 2005 and underwent the DR-70<sup>TM</sup> immunoassay test and other tests for cancer diagnosis. The patient group was defined as 42 adults out of the sample subjects who were newly diagnosed with cancer during the same time period when the DR-70<sup>TM</sup> immunoassay test was performed. Final confirmation of a malignant tumor was made by pathological analysis. Results: The mean DR-70<sup>TM</sup> level was 0.83±0.65μg/ml (range: 0.00 (0.0001)∼7.42μg/ml) in the control group (n=4,127) as opposed to 2.70±2.33μg/ml (range: 0.12∼9.30μg/ml) in the cancer group (n=42), and statistical significance was established (0.0001, Student t-test). When categorized by the type of malignant tumor, all cancer patients with the exception of the subgroups of colon and rectal cancer showed significantly higher mean DR-70<sup>TM</sup> levels compared with the control group (0.0001, Kruscal-Wallis test). The receiver operating characteristic (ROC) curve analysis revealed 1.091μg/ml as the best cut-off value. Using this cut-off value, the DR-70<sup>TM</sup> immunoassay produced a sensitivity of 71.4%, a specificity of 70.1%, a positive predictability of 69.4%, and a negative predictability of 69.2% (1). Conclusion: A significant increase in the mean DR-70<sup>TM</sup> value was observed in the cancer group (thyroidal, gastric, breast, hepatic and ovarian) com pared with the control group. In particular, the specificity and sensitivity of the DR-70<sup>TM</sup> immunoassay was relatively high in the subgroups of breast, gastric, and thyroidal cancer patients. There is need for further studies on a large number of malignant tumor patients to see how the DR-70<sup>TM</sup> level might be changed according to the differentiation grade and postoperative prognosis of the malignant tumor.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0